The overexpression of CHI3L1 in NPC cells is linked with tumour-associated inflammation and proliferation, and for this cancer, like several others, CHI3L1 is being considered not only as a diagnostic marker, but also as a potential therapeutic target. Here, CHI3L1 is linked to cancer.